Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

[OT]—I would question the business plan of any

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 727
Posts 110,447
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
Form 8.3 - [AbbVie Inc.] Dow Jones News - 1/17/2020 9:38:00 AM
SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results PR Newswire (US) - 1/17/2020 7:30:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 1/16/2020 9:16:00 AM
Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma's Impact on Daily Living PR Newswire (US) - 1/16/2020 7:30:00 AM
Form 8.3 -AbbVie Inc Dow Jones News - 1/14/2020 10:41:00 AM
Form 8.3 -AbbVie Inc Dow Jones News - 1/14/2020 10:28:00 AM
Form 8.3 - Abbvie Inc Dow Jones News - 1/13/2020 9:22:00 AM
EU Grants Conditional Approval to AbbVie-Allergan $63 Billion Deal Dow Jones News - 1/10/2020 10:14:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 1/10/2020 9:42:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 1/9/2020 9:47:00 AM
Form 8.3 - Abbvie Inc Dow Jones News - 1/8/2020 10:29:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 1/7/2020 10:00:00 AM
Form 8.3 - [Abbvie. Plc] Dow Jones News - 1/6/2020 9:59:00 AM
Ironwood and Allergan Announce Settlement Resolving LINZESS® (linaclotide) Patent Litigation Business Wire - 1/6/2020 8:00:00 AM
Allergan Units Settle Loestrin, Minastrin 24 Fe Lawsuits Dow Jones News - 1/6/2020 7:39:00 AM
Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 Fe an... PR Newswire (US) - 1/6/2020 7:00:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 1/3/2020 9:35:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 1/2/2020 9:58:00 AM
Form 8.3 - Abbvie Inc Dow Jones News - 12/31/2019 8:37:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/30/2019 10:50:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 12/30/2019 10:23:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 12/27/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 12/27/2019 9:50:00 AM
Form 8.3 - [ AbbVie Inc.] Dow Jones News - 12/27/2019 9:39:00 AM
Form 8.3 - [ AbbVie Inc.] Dow Jones News - 12/24/2019 9:50:00 AM
DewDiligence Member Level  Saturday, 05/11/19 05:03:00 PM
Re: RichardSawars post# 184
Post # of 197 
[OT]—I would question the business plan of any company that’s working on cellulite.

What’s differentiating about SOLY as compared to tattoo removal by laser?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist